Netflix Stock Price Soars After Earnings Report Record New Memberships
Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the
If you invested $1000 in Chipotle Mexican Grill (NYSE:CMG) 5 years ago, here's how much it's worth today
They say, “If it looks like a restaurant, cooks food like a restaurant, and serves food like a restaurant, then it’s probably a restaurant.”. However, this might not be how investors see Chipotle Mexican Grill ( NYSE:CMG ). Chipotle’s stock is currently trading at a P/E ratio of around 54, while many
Appia Announces Signing of Share Exchange Agreement with Ultra Rare Earth Inc.
Newsfile
14 minutes ago
Toronto, Ontario--(Newsfile Corp. - May 22, 2026) - Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQB: APAAF) (FSE: A010) (MUN: A010) (BER: A010) (the "Company" or "Appia") is pleased to announce that further to its Press Release dated November 3,
Paradigm Gold Adopts Semi-Annual Reporting
Newsfile
14 minutes ago
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2026) - Paradigm Gold Corporation (TSXV: PDQ) ("Paradigm" or the "Company") announces that it has adopted semi-annual financial reporting ("SAR") pursuant to the British Columbia Securities Commi
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
GlobeNewswire Inc.
14 minutes ago
WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the William Blair 46th Annual Growth Stock Confer
Stardust Metal Announces Fully-Subscribed Private Placement Led by Strategic Investor Daniel Earle
Newsfile
30 minutes ago
Highlights:Non-brokered private placement for gross proceeds of up to $5,260,000. Fully-subscribed placement led by mining industry leader Daniel Earle, President & CEO of Highlander Silver Corp., and Strategic Advisor to KEWA Financial Inc. and Andi
Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
39 minutes ago
SOUTH SAN FRANCISCO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced the pricing of an underwri
Galloper Gold Announces Fully-Funded Non-Brokered Private Placement
Newsfile
44 minutes ago
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2026) - Galloper Gold Corp. (CSE: BOOM) (OTC Pink: GGDCF) (the "Company" or "Galloper") is pleased to announce that it has arranged a non-brokered private placement (the "Private Placement") of a
Legend Power Systems Reports Q2 F2026 Financial Results
Newsfile
44 minutes ago
Conference Call Scheduled Today at 11am ESTVancouver, British Columbia--(Newsfile Corp. - May 22, 2026) - Legend Power Systems Inc. (TSXV: LPS) (OTCQB: LPSIF) ("Legend Power" or the "Company"), a global leader in commercial electrical system solution
New Break Announces Receipt of DTC Eligibility in the United States
Newsfile
44 minutes ago
Toronto, Ontario--(Newsfile Corp. - May 22, 2026) - New Break Resources Ltd. (CSE: NBRK) (OTCQB: NBRKF) (FSE: O91) ("New Break" or the "Company") is pleased to announce that its common shares are now eligible for electronic clearing and settlement in
Cassiar Gold Announces Closing of $5.5 Million Private Placement Offering
Newsfile
44 minutes ago
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2026) - Cassiar Gold Corp. (TSXV: GLDC) (OTCQX: CGLCF) ("Cassiar Gold" or the "Company") is pleased to announce that, further to its news release dated April 30, 2026, the Company has completed a
Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
GlobeNewswire Inc.
44 minutes ago
TARRYTOWN, N.Y., May 22, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the European Medicines Agency (EMA) has accepted for review under Accelerated Assessment the Marketing Authorization Application (MAA) fo
